All Posts
Review Highlights the Need to Increase Germline BRCA Mutation Testing in Males
August 12, 2024 9:00 amby Jax DiEugenio
Although the risks of cancer developing in females harboring germline BRCA1or BRCA2 mutations are understood and have propelled genetic testing and preventative measures for this population, more work is required to amplify the rates of this … Read more
Study Finds Higher Rates of Hereditary Cancer Mutations in Minority Populations Missed by Current Screening Guidelines
July 24, 2024 9:00 amby IPM staff
A new study from the Mayo Clinic finds that current screening protocols fail to catch a significant number of individuals with genetic mutations linked to hereditary breast and ovarian cancer syndrome (HBOC) and Lynch syndrome, which increase … Read more
Focused Radiation Is Safe, Effective for Metastatic Gynecologic Cancer Stereotactic ablative radiotherapy led to promising disease control in patients with metastatic gynecologic cancers, research showed.
July 22, 2024 9:00 am by Brielle Benyon
Stereotactic ablative radiotherapy (SABR) can be a promising and tolerable way to control gynecologic cancers, according to research published in JAMA Oncology.
SABR is a type of radiation that is highly focused. It provides an intense … Read more
Landmark Study Shows Elevated Cancer Risk for Women with Endometriosis
July 17, 2024 9:00 amby Huntsman Cancer Institute at the University of Utah
Newswise — A landmark study from researchers at Huntsman Cancer Institute at the University of Utah (the U), the Spencer Fox Eccles School of Medicine at the U, and Boston University … Read more
Stigmas About Palliative Care Are Harming Our Seriously Ill Patients
July 10, 2024 9:00 amby Stephen “Fred” Divers, MD, Chief Medical Officer & Julia Frydman, MD, Medical Director for Palliative Care
“I wish we had done this sooner.” This is something that we hear a lot from our patients and their families when they … Read more
Accredited Program Data May Set Benchmark for Adult Cancer Survivor Care
July 9, 2024 9:00 amby Roman Fabbricatore
Fertility and sexual health services appear to be offered to cancer survivors less often than other services at CoC-accredited practices.
Enforcing survivorship standards may help centers provide services to address the needs of cancer survivors, according to … Read more
Program Helps Medically Underserved, Minority Cancer Survivors Be More Active
July 3, 2024 9:00 amby Linda Wang
Physical activity can have many benefits for cancer survivors, from improving their quality of life to potentially making it less likely that their disease will come back. Yet studies have shown that many cancer survivors struggle to … Read more
Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteria —No difference in adverse events, clinical benefit, OS for patients with or without waivers
June 27, 2024 9:00 am by Charles Bankhead
Patients who received protocol waivers in a clinical trial of targeted anticancer therapy had outcomes similar to those who met all enrollment criteria, a large retrospective review showed.
Patients who received waivers had a clinical benefit rate … Read more
Estrogen-Only Hormone Therapy Linked to Increased Gynecologic Cancer Risk, But Estrogen-Progestin Combination Therapy Lowers It
June 1, 2024 9:00 amby Aaron Tallent
Key Points:
- Hormone replacement therapy (HRT) can reduce bothersome symptoms of menopause, but there is concern it may increase the incidence of certain cancers.
- An analysis from the Women’s Health Initiative shows that estrogen-only HRT may increase
Sydney researchers find differences in ovarian cancer risk factors by racial and ethnic groups
May 31, 2024 9:00 amResearchers conducted an international study of more than 11,000 ovarian cancer cases found selected ovarian cancer risk factors vary for women of different racial and ethnic backgrounds.
Led by Dr Melissa Merritt and Dr Nicola Meagher from the Daffodil Centre … Read more
For some endometriosis-related ovarian cancers, timing is everything
May 28, 2024 9:00 amby Van Andel Research Institute
Two types of endometriosis-related ovarian cancer arise from the same cells but likely at different stages of the menstrual cycle—a nuance that significantly influences treatment response, reports a recent study led by Van Andel Institute … Read more
Explaining Genetic and Tumor Biomarker Testing
May 23, 2024 9:00 amStudying human genes to explore how changes in DNA might influence the onset, progression, and treatment of cancer has become a cornerstone in today’s world. Over the past 25 years, progress has ramped up due to technology advances, increased access … Read more
Study reveals no survival benefit from systemic therapy in very advanced solid tumors
May 17, 2024 9:00 amClearity’s Perspective: Clearity knows that making decisions about continuing treatment when facing advanced ovarian cancer is complicated. Given the difficulty of these decisions, this article suggests having goals-of-care conversations with your medical providers when deciding whether or not to continue … Read more
AI partners with liquid biopsy for ‘robust’ identification of women with ovarian cancer
April 10, 2024 9:00 amby Josh Friedman
Key takeaways:
- AI-analyzed fragmentomes and protein biomarkers better distinguished women with ovarian cancer in screening.
- Liquid biopsy assay outperformed CA125 analysis alone.
An artificial intelligence-driven algorithm used a novel liquid biopsy assay to differentiate women with ovarian … Read more
Stress-Induced Immune Changes May Help Cancer Spread
April 2, 2024 9:00 amClearity’s Perspective: This article highlights the importance of learning ways to cope with and manage stress after an ovarian cancer diagnosis. The study, performed only on mice, suggests that there may be a link between overproduction of stress hormones and … Read more
ctDNA Offers Potential Biomarker for PARP Inhibitor Maintenance Therapy in Epithelial Ovarian Cancer
March 20, 2024 9:00 amClearity’s Perspective: At the SGO meeting several presentations described how circulating tumor DNA (ctDNA) may be a new, personalized, sensitive tool to help evaluate treatment de-escalation, monitor minimal residual disease (MRD), and track treatment response in ovarian cancer. The application … Read more
New microbiome insights could help boost immunotherapy for a range of rare cancers
March 1, 2024 9:00 amClearity’s Perspective: Previous research in different types of cancer has suggested that there is a relationship between a cancer patient’s gut microbiota (microorganisms that live in the digestive tract) composition and the response to immune checkpoint inhibitor therapy; however,
… Read more
Cancer Prevention Strategies Linked to Mortality Reduction in BRCA Carriers
February 29, 2024 9:00 amBy Mike Basset
Risk management strategies including bilateral salpingo-oophorectomy (BSO) for ovarian cancer and MRI surveillance for breast cancer were associated with a significant reduction in mortality for women with BRCA1/2 sequence variations, according to results from two cohort studies … Read more
Study Shows Disparities in Psychosocial Outcomes Among Women With Ovarian Cancer in Rural vs Urban Areas
February 23, 2024 9:00 amClearity’s Perspective: Clearity offers emotional support to people with ovarian cancer and their caregivers through our Steps Through OC program. If you would like personal one-to-one assistance with the stress and challenges associated with an ovarian cancer diagnosis, our team … Read more